Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.61 USD | +1.39% | +6.19% | -4.05% |
26/04 | North American Morning Briefing : Tech Still in -2- | DJ |
25/04 | Deutsche Bank Upgrades Acadia Healthcare to Hold From Sell, Price Target is $70 | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company is in debt and has limited leeway for investment
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.05% | 6.9B | C+ | ||
-14.58% | 85.02B | B- | ||
+15.05% | 82.37B | C+ | ||
+10.49% | 29.29B | C+ | ||
-10.17% | 17.21B | B | ||
-0.46% | 16.7B | A- | ||
-31.05% | 11.8B | - | - | |
+2.42% | 12.15B | A- | ||
+31.86% | 12.12B | B- | ||
-2.34% | 12.13B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ACHC Stock
- Ratings Acadia Healthcare Company, Inc.